ALC:NYSE
Alcon AG
73,64 US$
0,00%
(0,00) 1K
73,16 US$
arrow_downward
-0,65% (-0,48)todayBirjadan oldin
Savdolar yopilgan: 16-noy, 16:00:05 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Bozor kapitali
30,74 mlrd
Oʻrtacha hajm
2,15 mln
Hajmi
8,93 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,87
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Bozor kapitali
30,74 mlrd
Oʻrtacha hajm
2,15 mln
Hajmi
8,93 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,87
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ChartMill
·
49 daqiqa oldin
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
FOREX.com
·
1 soat oldin
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Investing.com
·
1 soat oldin
Why Goldman Sachs expects the S&P 500 to rally in 2027
Quartz
·
1 soat oldin
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25 ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
SektorHealth Care
Soha-
Veb-saytalcon.com